117 related articles for article (PubMed ID: 7781487)
21. Ocular surface residence times of artificial tear solutions.
Snibson GR; Greaves JL; Soper ND; Tiffany JM; Wilson CG; Bron AJ
Cornea; 1992 Jul; 11(4):288-93. PubMed ID: 1424647
[TBL] [Abstract][Full Text] [Related]
22. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models.
Ahn S; Eom Y; Kang B; Park J; Lee HK; Kim HM; Song JS
Curr Eye Res; 2018 May; 43(5):580-587. PubMed ID: 29419317
[TBL] [Abstract][Full Text] [Related]
23. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye.
Yokoi N; Takehisa Y; Kinoshita S
Am J Ophthalmol; 1996 Dec; 122(6):818-24. PubMed ID: 8956636
[TBL] [Abstract][Full Text] [Related]
24. Carbomer- versus cellulose-based artificial-tear formulations: morphologic and toxicologic effects on a corneal cell line.
Diebold Y; Herreras JM; Callejo S; Argüeso P; Calonge M
Cornea; 1998 Jul; 17(4):433-40. PubMed ID: 9676917
[TBL] [Abstract][Full Text] [Related]
25. Tear film normalization test: a new diagnostic test for dry eyes.
Latkany R; Lock BG; Speaker M
Cornea; 2006 Dec; 25(10):1153-7. PubMed ID: 17172889
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation.
Carracedo G; Pastrana C; Serramito M; Rodriguez-Pomar C
Acta Ophthalmol; 2019 Mar; 97(2):e162-e169. PubMed ID: 30280515
[TBL] [Abstract][Full Text] [Related]
27. [Corneal contact time of artificial tear solutions].
Marquardt R; Christ T
Klin Monbl Augenheilkd; 1986 Sep; 189(3):254-7. PubMed ID: 3784417
[TBL] [Abstract][Full Text] [Related]
28. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions.
López-Miguel A; Tesón M; Martín-Montañez V; Enríquez-de-Salamanca A; Stern ME; Calonge M; González-García MJ
Am J Ophthalmol; 2014 Apr; 157(4):788-798.e2. PubMed ID: 24412126
[TBL] [Abstract][Full Text] [Related]
29. Relationship between precorneal retention of viscous eye drops and tear fluid composition.
Ludwig A; van Haeringen NJ; Bodelier VM; Van Ooteghem M
Int Ophthalmol; 1992 Jan; 16(1):23-6. PubMed ID: 1537645
[TBL] [Abstract][Full Text] [Related]
30. Effect of laser in situ keratomileusis on tear stability.
Yu EY; Leung A; Rao S; Lam DS
Ophthalmology; 2000 Dec; 107(12):2131-5. PubMed ID: 11097583
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
Avisar R; Creter D; Levinsky H; Savir H
Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous measurement of tear film dynamics using wavefront sensor and optical coherence tomography.
Koh S; Tung C; Aquavella J; Yadav R; Zavislan J; Yoon G
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3441-8. PubMed ID: 20164455
[TBL] [Abstract][Full Text] [Related]
33. Relation between precorneal tear film stability and tear production rate in normal eyes.
Patel S; Farrell J; Bevan R
Optom Vis Sci; 1989 May; 66(5):300-3. PubMed ID: 2748107
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three lubricant eye drop solutions in dry eye patients.
Evangelista M; Koverech A; Messano M; Pescosolido N
Optom Vis Sci; 2011 Dec; 88(12):1439-44. PubMed ID: 21983118
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.
Greaves JL; Wilson CG; Galloway NR; Birmingham AT; Olejnik O
Acta Ophthalmol (Copenh); 1991 Aug; 69(4):432-6. PubMed ID: 1750310
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous periorbital electrical stimulation in the treatment of dry eye.
Pedrotti E; Bosello F; Fasolo A; Frigo AC; Marchesoni I; Ruggeri A; Marchini G
Br J Ophthalmol; 2017 Jun; 101(6):814-819. PubMed ID: 27660329
[TBL] [Abstract][Full Text] [Related]
38. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
[TBL] [Abstract][Full Text] [Related]
39. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
40. Retention and retention of effect of topical formulations in dry eye subjects.
Paugh JR; Nguyen AL; Huang P; Hwang JS
Optom Vis Sci; 2008 Sep; 85(9):873-9. PubMed ID: 18772723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
